The anticancer effects of andrographolide are also demonstrated in relation to human epidermoid carcinoma, breast cancer and human ovarian cancer cells via the nuclear factor-κB (NF-κB) signaling pathway. This evidence concerns the gene NFKB1 and breast cancer.